 |
|
General Psychiatry
Jack D. Barchas, MD;
Peter M. Marzuk, MD
JAMA. 1998;280:961-962.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
THE EVALUATION and treatment of mental illness are no longer the exclusive province of psychiatrists, psychologists, social workers, and other mental health professionals. As the number of pharmacological agents for mental disorders increases and these medications become simpler to use, many people with mental illness are being treated by family practitioners, internists, pediatricians, and gynecologists. This trend has important implications for the training and continuing education of all physicians, for the types of treatments patients receive, and for the public view of mental illness.
Recent substantive advances in the treatment of serious psychiatric disorders, including depression, schizophrenia, and substance abuse, new molecular hypotheses, and empirical findings from technologies such as brain imaging are altering the diagnosis and treatment of psychiatric illnesses. In this article, we review recent research that we consider representative of important new directions in the field of psychiatry.
Treatment of Depression
Systematic . . . [Full Text of this Article]
New Medications for Schizophrenia
Pharmacotherapy for Substance Abuse
Basic Research and Future Trends
From the Department of Psychiatry, New York Hospital-Cornell Medical Center, New York, NY. Dr Barchas is Editor of Archives of General Psychiatry.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
